Ischemia Reperfusion Injury Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014560664
Market Monitor Global
Oct-2021
Life Sciences
110 Pages

This report contains market size and forecasts of Ischemia Reperfusion Injury Therapeutics in Global, including the following market information:
Global Ischemia Reperfusion Injury Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Ischemia Reperfusion Injury Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ischemia Reperfusion Injury Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ischemia Reperfusion Injury Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Ischemia Reperfusion Injury Therapeutics Market Segment Percentages, By Type, 2020 (%)
ANV-6L15
APP-103
BAY-606583
EP-80317
GS-459679
KN-93
LH-021
Others

China Ischemia Reperfusion Injury Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Ischemia Reperfusion Injury Therapeutics Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Others

Global Ischemia Reperfusion Injury Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Ischemia Reperfusion Injury Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Ischemia Reperfusion Injury Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Ischemia Reperfusion Injury Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Nyken B.V.
Omeros Corporation
Opsona Therapeutics Limited
Orexo AB
Pharming Group N.V.
PledPharma AB
Prolong Pharmaceuticals
Proteo, Inc.
Prothix BV
Stealth BioTherapeutics Inc.
Zealand Pharma A/S
Amyndas Pharmaceuticals LLC
Angion Biomedica Corp.
Antipodean Pharmaceuticals, Inc.
Bayer AG
Biomedica Management Corporation
Bolder Biotechnology, Inc.
Curatis Pharma GmbH
Ensemble Therapeutics Corporation
Erimos Pharmaceuticals, LLC
Gilead Sciences, Inc.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Ischemia Reperfusion Injury Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ischemia Reperfusion Injury Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ischemia Reperfusion Injury Therapeutics Overall Market Size
2.1 Global Ischemia Reperfusion Injury Therapeutics Market Size: 2021 VS 2027
2.2 Global Ischemia Reperfusion Injury Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ischemia Reperfusion Injury Therapeutics Players in Global Market
3.2 Top Global Ischemia Reperfusion Injury Therapeutics Companies Ranked by Revenue
3.3 Global Ischemia Reperfusion Injury Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Ischemia Reperfusion Injury Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Ischemia Reperfusion Injury Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ischemia Reperfusion Injury Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Ischemia Reperfusion Injury Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Ischemia Reperfusion Injury Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ischemia Reperfusion Injury Therapeutics Market Size Markets, 2021 & 2027
4.1.2 ANV-6L15
4.1.3 APP-103
4.1.4 BAY-606583
4.1.5 EP-80317
4.1.6 GS-459679
4.1.7 KN-93
4.1.8 LH-021
4.1.9 Others
4.2 By Type - Global Ischemia Reperfusion Injury Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Ischemia Reperfusion Injury Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Ischemia Reperfusion Injury Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ischemia Reperfusion Injury Therapeutics Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Ischemia Reperfusion Injury Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Ischemia Reperfusion Injury Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Ischemia Reperfusion Injury Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Ischemia Reperfusion Injury Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Ischemia Reperfusion Injury Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Ischemia Reperfusion Injury Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Ischemia Reperfusion Injury Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Ischemia Reperfusion Injury Therapeutics Revenue, 2016-2027
6.3.2 US Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.3.3 Canada Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.3.4 Mexico Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Ischemia Reperfusion Injury Therapeutics Revenue, 2016-2027
6.4.2 Germany Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.4.3 France Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.4.4 U.K. Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.4.5 Italy Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.4.6 Russia Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.4.8 Benelux Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Ischemia Reperfusion Injury Therapeutics Revenue, 2016-2027
6.5.2 China Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.5.3 Japan Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.5.4 South Korea Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.5.6 India Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Ischemia Reperfusion Injury Therapeutics Revenue, 2016-2027
6.6.2 Brazil Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.6.3 Argentina Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ischemia Reperfusion Injury Therapeutics Revenue, 2016-2027
6.7.2 Turkey Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.7.3 Israel Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
6.7.5 UAE Ischemia Reperfusion Injury Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Nyken B.V.
7.1.1 Nyken B.V. Corporate Summary
7.1.2 Nyken B.V. Business Overview
7.1.3 Nyken B.V. Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.1.4 Nyken B.V. Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.1.5 Nyken B.V. Key News
7.2 Omeros Corporation
7.2.1 Omeros Corporation Corporate Summary
7.2.2 Omeros Corporation Business Overview
7.2.3 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.2.4 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.2.5 Omeros Corporation Key News
7.3 Opsona Therapeutics Limited
7.3.1 Opsona Therapeutics Limited Corporate Summary
7.3.2 Opsona Therapeutics Limited Business Overview
7.3.3 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.3.4 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.3.5 Opsona Therapeutics Limited Key News
7.4 Orexo AB
7.4.1 Orexo AB Corporate Summary
7.4.2 Orexo AB Business Overview
7.4.3 Orexo AB Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.4.4 Orexo AB Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.4.5 Orexo AB Key News
7.5 Pharming Group N.V.
7.5.1 Pharming Group N.V. Corporate Summary
7.5.2 Pharming Group N.V. Business Overview
7.5.3 Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.5.4 Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.5.5 Pharming Group N.V. Key News
7.6 PledPharma AB
7.6.1 PledPharma AB Corporate Summary
7.6.2 PledPharma AB Business Overview
7.6.3 PledPharma AB Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.6.4 PledPharma AB Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.6.5 PledPharma AB Key News
7.7 Prolong Pharmaceuticals
7.7.1 Prolong Pharmaceuticals Corporate Summary
7.7.2 Prolong Pharmaceuticals Business Overview
7.7.3 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.4.4 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.7.5 Prolong Pharmaceuticals Key News
7.8 Proteo, Inc.
7.8.1 Proteo, Inc. Corporate Summary
7.8.2 Proteo, Inc. Business Overview
7.8.3 Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.8.4 Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.8.5 Proteo, Inc. Key News
7.9 Prothix BV
7.9.1 Prothix BV Corporate Summary
7.9.2 Prothix BV Business Overview
7.9.3 Prothix BV Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.9.4 Prothix BV Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.9.5 Prothix BV Key News
7.10 Stealth BioTherapeutics Inc.
7.10.1 Stealth BioTherapeutics Inc. Corporate Summary
7.10.2 Stealth BioTherapeutics Inc. Business Overview
7.10.3 Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.10.4 Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.10.5 Stealth BioTherapeutics Inc. Key News
7.11 Zealand Pharma A/S
7.11.1 Zealand Pharma A/S Corporate Summary
7.11.2 Zealand Pharma A/S Business Overview
7.11.3 Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.11.4 Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.11.5 Zealand Pharma A/S Key News
7.12 Amyndas Pharmaceuticals LLC
7.12.1 Amyndas Pharmaceuticals LLC Corporate Summary
7.12.2 Amyndas Pharmaceuticals LLC Business Overview
7.12.3 Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.12.4 Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.12.5 Amyndas Pharmaceuticals LLC Key News
7.13 Angion Biomedica Corp.
7.13.1 Angion Biomedica Corp. Corporate Summary
7.13.2 Angion Biomedica Corp. Business Overview
7.13.3 Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.13.4 Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.13.5 Angion Biomedica Corp. Key News
7.14 Antipodean Pharmaceuticals, Inc.
7.14.1 Antipodean Pharmaceuticals, Inc. Corporate Summary
7.14.2 Antipodean Pharmaceuticals, Inc. Business Overview
7.14.3 Antipodean Pharmaceuticals, Inc. Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.14.4 Antipodean Pharmaceuticals, Inc. Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.14.5 Antipodean Pharmaceuticals, Inc. Key News
7.15 Bayer AG
7.15.1 Bayer AG Corporate Summary
7.15.2 Bayer AG Business Overview
7.15.3 Bayer AG Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.15.4 Bayer AG Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.15.5 Bayer AG Key News
7.16 Biomedica Management Corporation
7.16.1 Biomedica Management Corporation Corporate Summary
7.16.2 Biomedica Management Corporation Business Overview
7.16.3 Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.16.4 Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.16.5 Biomedica Management Corporation Key News
7.17 Bolder Biotechnology, Inc.
7.17.1 Bolder Biotechnology, Inc. Corporate Summary
7.17.2 Bolder Biotechnology, Inc. Business Overview
7.17.3 Bolder Biotechnology, Inc. Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.17.4 Bolder Biotechnology, Inc. Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.17.5 Bolder Biotechnology, Inc. Key News
7.18 Curatis Pharma GmbH
7.18.1 Curatis Pharma GmbH Corporate Summary
7.18.2 Curatis Pharma GmbH Business Overview
7.18.3 Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.18.4 Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.18.5 Curatis Pharma GmbH Key News
7.19 Ensemble Therapeutics Corporation
7.19.1 Ensemble Therapeutics Corporation Corporate Summary
7.19.2 Ensemble Therapeutics Corporation Business Overview
7.19.3 Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.19.4 Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.19.5 Ensemble Therapeutics Corporation Key News
7.20 Erimos Pharmaceuticals, LLC
7.20.1 Erimos Pharmaceuticals, LLC Corporate Summary
7.20.2 Erimos Pharmaceuticals, LLC Business Overview
7.20.3 Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.20.4 Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.20.5 Erimos Pharmaceuticals, LLC Key News
7.21 Gilead Sciences, Inc.
7.21.1 Gilead Sciences, Inc. Corporate Summary
7.21.2 Gilead Sciences, Inc. Business Overview
7.21.3 Gilead Sciences, Inc. Ischemia Reperfusion Injury Therapeutics Major Product Offerings
7.21.4 Gilead Sciences, Inc. Ischemia Reperfusion Injury Therapeutics Revenue in Global (2016-2021)
7.21.5 Gilead Sciences, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Ischemia Reperfusion Injury Therapeutics Market Opportunities & Trends in Global Market
Table 2. Ischemia Reperfusion Injury Therapeutics Market Drivers in Global Market
Table 3. Ischemia Reperfusion Injury Therapeutics Market Restraints in Global Market
Table 4. Key Players of Ischemia Reperfusion Injury Therapeutics in Global Market
Table 5. Top Ischemia Reperfusion Injury Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Ischemia Reperfusion Injury Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Ischemia Reperfusion Injury Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Ischemia Reperfusion Injury Therapeutics Product Type
Table 9. List of Global Tier 1 Ischemia Reperfusion Injury Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ischemia Reperfusion Injury Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Nyken B.V.
Omeros Corporation
Opsona Therapeutics Limited
Orexo AB
Pharming Group N.V.
PledPharma AB
Prolong Pharmaceuticals
Proteo, Inc.
Prothix BV
Stealth BioTherapeutics Inc.
Zealand Pharma A/S
Amyndas Pharmaceuticals LLC
Angion Biomedica Corp.
Antipodean Pharmaceuticals, Inc.
Bayer AG
Biomedica Management Corporation
Bolder Biotechnology, Inc.
Curatis Pharma GmbH
Ensemble Therapeutics Corporation
Erimos Pharmaceuticals, LLC
Gilead Sciences, Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE